Tanning Beds Are the ‘Worst Offenders’ for Skin Cancer, Dermatologist Says

News
Video

Tanning beds cause an increased risk of skin cancer among young people — especially those who have a family history of skin cancer.

Skin cancers are known to be the most common form of cancer in the United States, according to the Centers for Disease Control and Prevention, and tanning beds and the sun may be contributing toward these high numbers.

Merkel cell, basal cell and squamous cell carcinomas are among some of the most common types of skin cancer, with Merkel cell carcinoma gaining more awareness after singer-songwriter Jimmy Buffet died on Sept. 1 from the disease.

However, the “worst offender” regarding the increased risk of skin cancer is the use of tanning beds in younger people, Dr. Beth Goldstein, a dermatologist who specializes in skin cancer at the Central Dermatology Center in Chapel Hill, North Carolina, told CURE®.

“We’re seeing people in their 20s and 30s (and tanning beds) markedly increase your risk of all forms of skin cancer, including doubling to tripling their risk of melanoma, if not more,” she said. “There are genetics that go with that, too. So, if you have a family history of skin cancer, particularly melanoma, and you did (use) tanning beds, then certainly, earlier on is when you may start seeing melanoma.”

LEARN MORE: Types of Skin Cancer and Their Treatments

Goldstein told CURE® about the increased risk of skin cancer and melanomas caused by tanning beds and damage caused by the sun:

Transcript:

We're seeing people in their 20s and 30s that it markedly increases your risk of all forms of skin cancer, including doubling to tripling their risk of melanoma, if not more. There are genetics that go with that, too. So, if you have a family history of skin cancer, and particularly melanoma, and you did tanning beds, then certainly, earlier on is when you may start seeing those. For men over 50, are the other age group or demographic that's having increase in melanoma. But for young people, particularly young women, although young men as well, we see where they get multiple melanomas as a young person, not just that one or two, but they can have many. And so, if you've had a history of being in a tanning bed, and you've started to get changes in your moles, flat moles or raised moles that can be just a light brown changing spot. Gray doesn't have to be dark or black to be a problem. It can be pink even. So, if you're noticing changes in your spots, you really need to come in and be seen about every four to six months if you have that history.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE